Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03875235
Brief Title: Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) (TOPAZ-1)

First Submitted : March 13, 2019
First Submitted that Met QC Criteria : March 13, 2019
First Posted : March 14, 2019

Last Update Submitted that Met QC Criteria : December 10, 2019
Last Update Posted : December 12, 2019